Product Information |
DR-XY47366_PI_01.pdf
|
Registration Number |
DR-XY47366
|
Generic Name |
Fluticasone furoate + Umeclidinium (as bromide) +
Vilanterol (as trifenatate)
|
Brand Name |
Trelegy Ellipta
|
Dosage Strength |
100 mcg/62.5 mcg/25 mcg
|
Dosage Form |
Dry Powder For Inhalation
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
-
|
Packaging |
Alu blister strip fitted in a plastic device inhaler enclosed in sealed foil laminate tray with desiccant packet x 30 actuation doses (Box of l's) and 14 actuation doses (Box of l's) [as Physician's Sample)
|
Manufacturer |
Glaxo Operations UK Ltd.
|
Country of Origin |
United Kingdom
|
Trader |
|
Importer |
GlaxoSmithKline Philippines, Inc.
|
Distributor |
GlaxoSmithKline Philippines, Inc.
|
Application Type |
Monitored Release
|
Issuance Date |
08 September 2021
|
Expiry Date |
08 September 2024
|